The biggest FDA approval of the third quarter was for a product that has already been used in more than 130 countries. August saw the full approval of Pfizer and BioNTech’s COVID-19 vaccine Comirnaty for those aged 16 and over, 8 months after it was initially granted emergency use authorization…

Click here  to original publication.

Fonte:  volume 20 | November 2021 | 807 biobusiNess briefs Nature